Business Continuity Risk from Large-Scale Disasters and Major Infectious Diseases
First written in FY2016. 3 of 7 entries say "Restated". Latest entry: FY2021.
The whole theme swung hardest in 2020: 22 of 111 companies on the "Worse" side.
98 other companies' latest entry also says "Restated".
- FY2021RestatedAnnual report
「In light of these risks, the company has established systems for business continuity in accordance with government guidelines and conducts disaster preparedness drills.」
The establishment of business continuity systems and implementation of disaster preparedness drills in preparation for large-scale disasters and serious infectious diseases are ongoing. - FY2020RestatedAnnual report
「In light of these risks, the company has established systems for business continuity in accordance with government guidelines and conducts disaster preparedness drills.」
The establishment of business continuity systems and implementation of disaster preparedness drills in preparation for large-scale disasters and serious infectious diseases are ongoing. - FY2020-Q3WorsenedAnnual report
「If the spread and prevalence of COVID-19 or another serious infectious disease continues for an extended period, development projects in the information services business and crypto-asset-related business could be delayed or suspended, while the financial instruments trading business could see a decline in investor demand.」
The impact of COVID-19 was specified as business-specific risks, including delays or suspensions of development projects and reduced investment demand in the financial instruments trading business. - FY2020-Q2MaterialisedAnnual report
「During the cumulative second-quarter consolidated accounting period, ¥26 million had been deducted from net sales as a valuation loss on crypto assets for which no active market existed. Because all of those crypto assets were sold in February 2020, an additional ¥1 million was deducted from net sales as a loss on the transfer of crypto assets. In addition, in the financial instruments trading business, trading in e-warrants became more active as the stock market changed sharply due to the impact of COVID-19, but trading income deteriorated because stock market volatility exceeded expectations.」
The impact of a serious infectious disease on the business and markets materialized as sharp stock market fluctuations and deterioration in trading income in the financial instruments trading business. - FY2020-Q1WorsenedAnnual report
「The deterioration in trading income caused by turmoil in financial markets following the sudden deterioration in relations between the United States and Iran in January and the global spread of pneumonia caused by the novel coronavirus, together with increased upfront investment costs for developing new products, temporarily weakened earnings.」
A specific event, the global spread of pneumonia caused by the novel coronavirus, was added to the previously general infectious disease risk. However, this filing does not describe direct damage to offices or personnel. - FY2017RestatedAnnual report
「The company has established systems for business continuity in accordance with government guidelines and conducts disaster preparedness drills. However, if a large-scale disaster or serious infectious disease occurs, its offices, systems and many of its employees could be affected.」
The establishment of business continuity systems and implementation of disaster preparedness drills continue, while the risks of large-scale disasters and infectious diseases remain disclosed. - FY2016First statedAnnual report
「The company has established systems for business continuity in accordance with government guidelines and conducts disaster preparedness drills. However, if a large-scale disaster or serious infectious disease occurs, its offices, systems and many of its employees could be affected.」
The disclosure describes the establishment of business continuity systems and the implementation of disaster preparedness drills, while identifying the impact of large-scale disasters and serious infectious diseases on the business, systems and personnel as risks.